Josh Fritzler

Josh Fritzler is the Chief Financial Officer of Olympia Pharmaceuticals, a company that provides compounded GLP-1 medications, including semaglutide, to tens of thousands of patients weekly. He has expressed concerns about the stability of the national supply of GLP-1 drugs, particularly regarding continuity of care for patients as the FDA has recently declared an end to shortages of FDA-approved versions of these medications.